Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences
- 1 January 2014
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 20 (1), 75-83
- https://doi.org/10.4158/ep13090.ra
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 DiabetesDiabetes Care, 2012
- Insulin aspart has a shorter duration of action than human insulin over a wide dose-rangeDiabetes, Obesity and Metabolism, 2012
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trialThe Lancet, 2012
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialThe Lancet, 2012
- Insulin Preparations with Prolonged EffectDiabetes Technology & Therapeutics, 2011
- Guidelines for Optimal Bolus Calculator Settings in AdultsJournal of Diabetes Science and Technology, 2011
- Glucose Clamp Algorithms and Insulin Time-Action ProfilesJournal of Diabetes Science and Technology, 2009
- Bolus Calculator: A Review of Four “Smart” Insulin PumpsDiabetes Technology & Therapeutics, 2008
- Insulin AnaloguesNew England Journal of Medicine, 2005
- Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes MellitusJama-Journal Of The American Medical Association, 2003